US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on April 27, 2025

Statin pills could increase survival chances of people with blood cancers, study finds

Statin pills could increase survival chances of people with blood cancers, study finds

Statin pills provide patients with some blood cancers better chances to survival the disease. SHARJAH, EMIRATE OF SHARJAH, UNITED ARAB EMIRATES, April 27, 2025 /⁨EINPresswire.com⁩/ -- People on cholesterol-lowering statins and suffering from certain blood …

Vision Lifesciences Strengthens US Leadership with Strategic Senior Appointment

Vision Lifesciences Strengthens US Leadership with Strategic Senior Appointment

Industry Veteran Robert Davis Joins as Senior Partner to Lead US Operations and Enhance Cross-Border Capabilities NEW YORK, NY, UNITED STATES, April 27, 2025 /⁨EINPresswire.com⁩/ -- Vision Lifesciences, a specialized financial advisory firm focused on the …

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …

Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test

Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test

Comprehensive epigenomic platform enables systematic and quantitative prediction of tumor gene expression from cell-free DNA Genes include key targets for next generation precision medicines, such as NECTIN4, B7H4, HER3, DLL3, MUC1, MET, and HER2 and …

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of ABP-102/CT-P72 HER2-positive cancers represent up to 30 …

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting

REDWOOD CITY, Calif., April 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced new clinical data for …

Mitolyn Reviews: DO NOT Spend A Dime Until You’ve Read This Report?

Mitolyn Reviews: DO NOT Spend A Dime Until You’ve Read This Report?

Albany, New York, April 27, 2025 (GLOBE NEWSWIRE) -- Various weight loss supplements make exaggerated promotional statements that obscure the real value of actual customer feedback with measurable results. The health and wellness industry welcomes Mitolyn …

SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

STAMFORD, Conn., April 27, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company anticipates the Committee for …

BDSLCCI Framework strengthens Small & Medium Enterprises with Enhanced Cybersecurity & Compliance: SME Research Insights

BDSLCCI Framework strengthens Small & Medium Enterprises with Enhanced Cybersecurity & Compliance: SME Research Insights

Foundational Research and Practical Implementation of the BDSLCCI Cybersecurity Framework to Strengthen Security and Compliance for Small and Medium Enterprises SAN DIEGO, CA, UNITED STATES, April 26, 2025 /⁨EINPresswire.com⁩/ -- Small and Medium …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service